Session Summary
The use of i2b2 for determining feasibility of clinical studies and clinical trials, focusing on the use of i2b2 in networks across the country, and novel approaches to allowing investigators to perform feasibility studies using i2b2-based client tools.
Douglas MacFadden
Chief Informatics Officer
Harvard Catalyst
P1: SHRINE Update
- Review of all the new features added to the SHRINE Software
Nich Wattanasin, MS
Corporate Team Lead
Partners HealthCare
P2: Using SHRINE and i2b2 for Feasibility Studies
- New features added to SHRINE and i2b2 Web Clients to help improve the workflow of identifying and extracting patient sets for clinical studies or trials.
View Presentation
Jack London, MD
P3:
Kavi Wagholikar, PhD
Assistant in Computer Science
Massachusetts General Hospital